HB18-1148

HB18-1148 - Stage Four Advanced Metastatic Cancer Step Therapy

Passed/Signed into Law
Concerning the prohibition against a carrier requiring step therapy for covered persons with stage four advanced metastatic cancer.

The bill prohibits a carrier that issues a health benefit plan that covers treatment for stage four advanced metastatic cancer from requiring a cancer patient to undergo step therapy prior to receiving a drug approved by the United States food and drug administration if use of the approved drug is consistent with best practices for treatment of the cancer and as long as the drug is on the carrier's prescription drug formulary.

(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

 

Latest update: April 9, 2018
04/09/2018 - Governor Signed
04/04/2018 - Sent to the Governor
04/04/2018 - Signed by the President of the Senate
04/04/2018 - Signed by the Speaker of the House
03/29/2018 - Senate Third Reading Passed - No Amendments
03/28/2018 - Senate Second Reading Passed - No Amendments
03/27/2018 - Senate Second Reading Laid Over Daily - No Amendments
03/26/2018 - Senate Second Reading Laid Over Daily - No Amendments
03/23/2018 - Senate Second Reading Laid Over Daily - No Amendments
03/21/2018 - Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
03/05/2018 - Introduced In Senate - Assigned to Health & Human Services
02/26/2018 - House Third Reading Passed - No Amendments
02/23/2018 - House Second Reading Passed with Amendments - Committee
02/20/2018 - House Committee on Public Health Care & Human Services Refer Amended to House Committee of the Whole
01/31/2018 - Introduced In House - Assigned to Public Health Care & Human Services